Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
3.17M
-
Shares change
-
-112K
-
Total reported value, excl. options
-
$16.9M
-
Value change
-
-$559K
-
Put/Call ratio
-
0.98
-
Number of buys
-
15
-
Number of sells
-
-19
-
Price
-
$5.35
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2018
50 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2018.
XBiotech Inc. - Common Shares, no par value (XBIT) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.17M shares
of 30.8M outstanding shares and own 10.29% of the company stock.
Largest 10 shareholders include BlackRock Inc. (906K shares), VANGUARD GROUP INC (820K shares), STATE STREET CORP (317K shares), NORTHERN TRUST CORP (215K shares), GEODE CAPITAL MANAGEMENT, LLC (170K shares), SCHWAB CHARLES INVESTMENT MANAGEMENT INC (88.1K shares), Bank of New York Mellon Corp (61.5K shares), CREDIT SUISSE AG/ (54.8K shares), TIAA CREF INVESTMENT MANAGEMENT LLC (45.7K shares), and ALLIANCEBERNSTEIN L.P. (42.7K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.